Biologically active peptides structurally related to regions within growth hormones
CA 1267995 C · Owner: Amgen · Inventors: Jones, Theodore; Rudman, Christopher G.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
30 -, "BIOLOGICALLY ACTIVE PEPTIDES STRUCTURALLY RELATED TO REGIONS WITHIN GROWTH HORMONES", ABSTRACT Disclosed are novel synthetic peptides having primary structural homology to a continuous sequence of amino acid residues of human growth hormone in a region spanning positions thirty-two to forty-six ("hGH32-46"' or "deletion peptide"). In preferred forms peptides of, the invention comprehend: duplicate portions (i.e. sequence fragments) of hGH32-46; stereochemical analogs and fragment analogs of hGH32-46 including one or more amino acid residues in D-isomeric configuration; and "interspecies" analogs and fragment analogs of hGH32-46 including one or more non-homologous amino acid residues …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted April 17, 1990. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended April 17, 2007.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.